Revisiting the usefulness of cold agglutinin test and direct Coombs test for bedside diagnosis of paediatric Mycoplasma pneumoniae pneumonia: a prospective observational study
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261529Keywords:
Mycoplasma pneumoniae, Bedside cold agglutinin test, Direct coombs test, Paediatric pneumonia, Atypical pneumonia, Hospital stayAbstract
Background: Mycoplasma pneumoniae is an important cause of community‑acquired pneumonia in children. Access to specific serological assays is limited in many resource‑constrained settings, necessitating evaluation of simple bedside diagnostic tests such as cold agglutinin test (CAT).
Methods: In this prospective observational study, children admitted with radiologically confirmed lobar pneumonia that showed no response to beta-lactams were evaluated with direct Coombs test (DCT) and CAT, and results were compared with Mycoplasma pneumoniae IgM serology as the reference standard. Clinical profile, inflammatory markers, treatment response and outcomes including need for paediatric intensive care and length of hospital stay were also recorded.
Results: Among IgM‑positive children, normal total leucocyte counts were significantly more frequent than in IgM‑negative cases, while erythrocyte sedimentation rate was commonly elevated, supporting an atypical pneumonia pattern. DCT showed low sensitivity and poor negative predictive value, whereas CAT demonstrated very high specificity and positive predictive value, making it a useful rule‑in test but unsuitable as a stand‑alone screening tool. CAT positivity was associated with a significantly longer duration of hospital stay, indicating more severe or protracted clinical course among children with demonstrable cold agglutinins.
Conclusions: Mycoplasma pneumoniae pneumonia in this cohort was characterized by normal total leucocyte counts with raised erythrocyte sedimentation rate, and CAT emerged as a highly specific rule‑in test, though it could not replace confirmatory serology testing.
References
Cheng JH, Huang YC, Lin TY, Chang LY, Wong KS, Huang LM. A rapid cold agglutinin test in Mycoplasma pneumoniae infection in children. Acta Paediatr Scand. 1990;79(8 9):958 62.
Kim CH, Shin SM, Lee KY, Jung MH, Bahn JW. Diagnostic significance of cold agglutinin and anti-Mycoplasma antibody titers in pediatric pneumonia. Yeungnam Univ J Med. 1989;6(2):319 27.
Ozkaya S, Findik S, Atici AG, Yildiz F. Cold agglutination test and Mycoplasma pneumoniae: a retrospective study. Turk Thorac J. 2019;20(4):275 80.
Lin LJ, Chiu NC, Lee KS, Chiu YY, Chi H, Huang FY, et al. Diagnostic value of serological studies for Mycoplasma pneumoniae infection in pediatric community acquired pneumonia. Asian Pac J Allergy Immunol. 2018;36(2):79 86.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697 728.
Kumar S, Saigal SR, Sethi GR. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community acquired lower respiratory tract infections. Indian J Med Res. 2018;147(6):667 76.
Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57(3):1521 3.
Chavan C, Patankar R, Gadgil A, Shankar D, Janani N, Prabu D. Detection of macrolide resistant Mycoplasma pneumoniae in children with lower respiratory tract infection. J Pure Appl Microbiol. 2023;17(1):338-44.
Jindal SK. Community acquired pneumonia in children: epidemiology and etiology. Indian J Pediatr. 2010;77(4):441 4.
Gaillard EA, Kantar A, Launes C. Community acquired pneumonia in children-clinical features and diagnosis. Paediatr Respir Rev. 2016;20:60 7.
Bradley JS, Byington CL, Shah SS. The management of community acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25 76.
Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children. PLoS One. 2016;11(5):e0156465.
Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010;16(3):162 9.
Salaria M, Singh M. Reply. Indian Pediatr. 2002;39:1061-1062. Available from: https://www.indianpediatrics.net/nov2002/nov-1061-1062.htm. Accessed on 06 February 2026.
Surendar K, Malay S. Mycoplasma pneumonia: Clinical features and Management. Lung India. 2010;27(2):75-85.
Cherian CS, Nair TS, Sushama Bai S, Oommen S. Prevalence and clinical profile of Mycoplasma pneumonia respiratory infection in children: a hospital-based study. Int J Contemporary Pediat. 2016;3:612-5.
Downloads
Published
How to Cite
Issue
Section
